Signal #119226 · SEC 8-K

$DNLI SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $DNLI filing catalyst

Why did $DNLI trigger an AI stock catalyst alert?

$DNLI triggered a Stock Catalyst AI alert on 2026-11-03 00:00:00 UTC for a SEC 8-K filing (AI Score: +6.5/10). Headline: Denali Therapeutics Reports Q3 AVLAYAH Revenue of $17.8M, Guides Q4 to $30M-$32M. Key points: - Net product revenue for AVLAYAH reached $17.8M in its second commercial quarter. - Q4 2026 net product revenue guided to $30.0M–$32.0M, reflecting sequential acceleration. - Net income turned positive for the quarter driven by product revenue and other income/gains.

How did $DNLI stock react after the SEC filing?

After the SEC 8-K for $DNLI, observed market reaction: T0 price $19.45. Past moves do not guarantee future results.

Where can I get real-time $DNLI SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $DNLI via Telegram and the VIP Web Terminal from €10/month.

$DNLI

$DNLI – Denali Therapeutics Reports Q3 AVLAYAH Revenue of $17.8M, Guides Q4 to $30M-$32M

Denali Therapeutics Inc.

2026-11-03 00:00:00 UTC · SEC 8-K · All $DNLI

Unlocked archive · Analyzed in <2s at T0

Bullish AI Sentiment (+6.5 / 10)

Net product revenue for AVLAYAH reached $17.8M in its second commercial quarter.
Q4 2026 net product revenue guided to $30.0M–$32.0M, reflecting sequential acceleration.
Net income turned positive for the quarter driven by product revenue and other income/gains.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →